The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

27 articles for JW Ellingboe


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification and characterization of acidic mammalian chitinase inhibitors.EBI
Pfizer
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket.EBI
Wyeth Research
Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.EBI
Wyeth Research
Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists.EBI
Wyeth Research
Identification of a new class of small molecule C5a receptor antagonists.EBI
Wyeth Research
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.EBI
Wyeth Research
Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors.EBI
Wyeth Research
Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.EBI
Wyeth Research
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.EBI
Wyeth Research
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.EBI
Wyeth Research
1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitors.EBI
Wyeth Research
Design and synthesis of 2,3,4,9-tetrahydro-1H-carbazole and 1,2,3,4-tetrahydro-cyclopenta[b]indole derivatives as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.EBI
Wyeth Research
Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.EBI
Wyeth Research
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.EBI
Wyeth Research
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.EBI
Wyeth Research
Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.EBI
Wyeth Research
Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase.EBI
Wyeth Research
Design and synthesis of oxadiazolidinediones as inhibitors of plasminogen activator inhibitor-1.EBI
Wyeth Research
Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.EBI
Wyeth Research
Pyrazolopyrimidine-2,4-dione sulfonamides: novel and selective calcitonin inducers.EBI
Wyeth Research
Novel and selective calcitonin-inducing agents.EBI
Wyeth-Ayerst Research
Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.EBI
Wyeth-Ayerst Research
Pyrido[2,3-d]pyrimidine angiotensin II antagonists.EBI
Wyeth-Ayerst Research
Pyridinone and pyrimidinone derivatives as factor XiaBDB
Ono Pharmaceutical
Sulfoximine substituted quinazolines for pharmaceutical compositionsBDB
Evotec International
Inhibitors of lysine specific demethylase-1BDB
Celgene Quanticel Research
6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).BDB
Glaxosmithkline